We further investigated the potential function of IKBKE in TKI resistance in RCC patients and found that patients with sunitinib resistance exhibited higher IKBKE expression (Figure 3C up); however, there was no significant correlation between IKBKE expression and sorafenib sensitivity in RCC patients (Figure 3C down). Here, IKBKE is linked to renal cell carcinoma.